Related Posts
Tukysa is a kinase inhibitor recommended...
The FDA has approved a...
Enhertu (Trastuzumab deruxtecan) is an...
About Ustekinumab: The Ustekinumab comes...
Cryopyrin-Associated Periodic Syndromes (CAPS) comprise...
Recent Posts
- Takeda’s Qdenga Vaccine: A Breakthrough in Dengue Prevention Coming to India
- New Acute Myeloid Leukemia (AML) Treatments
- Indian Company Can Manufacture Risdiplam for Spinal Muscular Atrophy (SMA)
- X-Linked Hypophosphatemia: Symptoms, Diagnosis, & Treatment
- FDA Approves Qfitlia (Fitusiran) for Hemophilia A or B, with or without Factor Inhibitors